Submitted by Anonymous (not verified) on
Product Form
inject
API Generic 1
amivantamab
API Strength 1
350 mg/7mL
Patent Expiration
Patent Number
  • US 9695242
  • US 9580508
  • US 9593164
Sub Title
RYBREVANT